Adverum Biotechnologies Inc
ADVM
ISIN US00773U2078 / Valor 133481885
Adverum Biotechnologies Inc
UMushroom community rating:
About company
Adverum Biotechnologies Inc. is a clinical-stage biotechnology company focused on developing gene therapies for ocular diseases. The company leverages its proprietary intravitreal (IVT) platform to create durable, single-administration treatments aimed at reducing the need for frequent ocular injections. Its lead product candidate, ixoberogene soroparvovec (Ixo-vec, formerly ADVM-022), is being evaluated as a one-time IVT injection for patients with neovascular or wet age-related macular degeneration. Adverum's approach seeks to address the limitations of current treatment methods, aiming to preserve vision and potentially transform the standard of care for these prevalent and debilitating eye conditions.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
3103 M
Market cap (USD)
117,115
Daily traded volume (Shares)
6.9 / 6.15
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
